News

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a ...
Researchers says the drugs could be a treatment for obese people with asthma who are ‘often resistant’ to steroids ...
Tirzepatide helps obese adults lose over 15% of body weight in 52 weeks—and retain much of it even six months after stopping ...
A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...
Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, among women than men.
Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...
GLP-1 drugs for diabetes and weight loss are difficult for some people to inject weekly. A new slow-release gel, tested in rats, could help.
Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...